| Literature DB >> 17173674 |
Samuel Kariuki1, Gunturu Revathi, Nyambura Kariuki, John Kiiru, Joyce Mwituria, Charles A Hart.
Abstract
BACKGROUND: In sub-Saharan Africa community-acquired non-typhoidal Salmonella (NTS) is a major cause of high morbidity and death among children under 5 years of age especially from resource poor settings. The emergence of multidrug resistance is a major challenge in treatment of life threatening invasive NTS infections in these settings.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17173674 PMCID: PMC1764016 DOI: 10.1186/1471-2180-6-101
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Number of NTS isolates from children by month. A higher number of isolations occurred during the rainy season in May and June compared to the rest of the year (p < 0.001).
Characteristics of children with NTS stratified by blood and stool culture positivity
| Characteristic [No. (%)] | Stool -ve blood +ve (N = 170) | Stool +ve Blood +ve (N = 28) | Stool +ve blood -ve (N = 134) | p-value |
| Sex | ||||
| Male | 98 (57.6) | 17 (60.7) | 76 (57.6) | |
| Female | 72 (42.3) | 11 (39.3) | 56 (42.4) | 0.931 |
| Mean age (months) | 22 | 24 | 24 | 0.7681 |
| Key Clinical features | ||||
| Fever | 105 (61.8) | 12 (42.9) | 37 (27.6) | p < 0.001 |
| Diarrhoea | 69 (40.6) | 26 (92.9) | 89 (66.4) | p < 0.001 |
| Vomiting | 44 (28.9) | 2 (7.1) | 66 (49.3) | p < 0.001 |
| Days hospitalised | ||||
| Range | 1–60 | 1–30 | 1–23 | - |
| Median | 9 | 7 | 2 | 0.004 |
| NTS serotypes | ||||
| | 93 (54.7) | 11 (39.3) | 92 (68.7) | 0.04 |
| | 57 (33.5) | 8 (25) | 29 (21.6) | 0.71 |
| Other serotypes | 20 (11.8) | 9 (32.1) | 13 (9.7) | 0.13 |
Figure 2Clinical presentation of NTS infection according to age group. More children under the age of 3 years tended to get invasive disease compared to older children (over 3 years) who had a higher proportion with gastroenteritis.
NTS presentation according to classification of homes of index cases
| Residence and No. (%) of cases | ||||
| Presentation | Slum N = 128 | Lower middle and middle class n = 123 | Upper class n = 81 | p-value |
| Diarrhoea alone | 54(42.2) | 57(46.4) | 56(69.1) | p < 0.001 |
| Diarrhoeal+ Invasive NTS | 12(9.4) | 19(15.4) | 11(13.6) | p = 0.427 |
| Invasive NTS alone | 62(48.4) | 47(38.2) | 14(17.3) | p < 0.001 |
MIC using the E-Test of 10 antimicrobial agents for 198 NTS isolates from blood cultures (BC) and 162 NTS isolates from stools (ST) at two Hospitals in Nairobi, Kenya (2002–2004).
| Antimicrobial | Minimum Inhibitory Concentration (μg/ml) | |||||
| Agent | Range | MIC90 | % Resistant | |||
| BC | ST | BC | ST | BC | ST | |
| Ampicillin | 0.25->256 | 0.25->256 | 64 | 64 | 54 | 49 |
| Co-amoxiclav | 0.75->256 | 0.38–32 | 16 | 16 | 8 | 13 |
| Cefuroxime | 2->256 | 2->256 | 32 | 32 | 30 | 28 |
| Ceftriaxone | 0.094–16 | 0.023–6 | 2 | 0.12 | 0 | 0 |
| Gentamicin | 0.06->256 | 0.125->256 | 8 | 6 | 16 | 9 |
| Co-trimoxazole | 0.064->32 | 0.032->32 | 32 | 32 | 46 | 48 |
| Chloramphenicol | 0.19->256 | 0.19->256 | 32 | 32 | 26 | 22 |
| Tetracycline | 0.064->256 | 0.75->256 | 128 | 32 | 51 | 39 |
| Nalidixic acid | 1.5->256 | 1.5->256 | 3 | 8 | 12 | 6 |
| Ciprofloxacin | 0.064–4 | 0.008–0.125 | 0.125 | 0.032 | 0 | 0 |
Most common antibiotic treatment choices used for NTS infections.
| No (%) treated | Overall % Resistance | |
| Cefuroxime | 77 (32) | 30 |
| Ceftriaxone | 64 (26.4) | 0 |
| Gentamicin | 42 (17.4) | 16 |
| Co-amoxiclav | 29 (12) | 8 |
| Ampicillin | 21 (8.7) | 48 |
| Cotrimoxazole | 8 (0.03) | 46 |
Figure 3Representative PFGE patterns of XbaI-digested S. Typhimurium from cases from children with bacteraemia. Lane M, 50 kb molecular size standard; Lanes 1 to 9, S. Typhimurium from PFGE pattern 1; Lanes 10 and 11, S. Typhimurium from PFGE pattern 2; Lane 12 S. Typhimurium from PFGE pattern 3. Using either of the two enzymes, XbaI or SpeI, PFGE patterns of the isolates were within 1–3 band differences.
Figure 4Representative PFGE patterns of XbaI-digested S. Enteritidis from cases from children with bacteraemia. Lane M, 50 kb molecular size standard. Lanes 1 and 2, S. Enteritidis from PFGE pattern 1; Lanes 3 and 4, S. Enteritidis from PFGE pattern 2.